We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CGNSF market cap is 340.32k. The company's latest EPS is CAD -0.0830 and P/E is 0.00.
Year End January 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 45k |
Operating Income | -3.23M | -1.62M | -1.79M | -9.44M | -5.07M |
Net Income | -4.19M | -2.65M | -1.93M | -13.13M | -7.43M |
Year End January 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 716k | 748k | 1.83M | 2.01M | 2.83M |
Total Liabilities | 237k | 1.01M | 965k | 7.68M | 12.72M |
Total Equity | 479k | -263k | 863k | -5.68M | -9.89M |
Year End January 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -3.49M | -1.86M | -1.96M | -3.21M | -5.94M |
Investing | 3.32M | 107k | -49k | -100k | -70k |
Financing | 298k | 2.08M | 2.79M | 3.33M | 6.88M |
Market Cap | 340.32k |
Price to Earnings Ratio | 0.00 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 89.56M |
Average Volume (1 week) | 31.68k |
Average Volume (1 Month) | 26.43k |
52 Week Change | -74.67% |
52 Week High | 0.0228 |
52 Week Low | 0.0011 |
Spread (Intraday) | 0 (48%) |
Company Name | Cognetivity Neurosciences Ltd (PK) |
Address |
suite 1500, 1055 w. georgia st vancouver, british columbia V6E 4N7 |
Website | https://www.cognetivity.com |
Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions